Laboratorio Farmaceutico Erfo Logo

Laboratorio Farmaceutico Erfo

ERFO | XMIL

Overview

Corporate Details

ISIN(s):
IT0005497836 (+1 more)
LEI:
8945005CB564D0OBQQ85
Country:
Italy
Address:
VIALE GEKI RUSSO, SNC (PONTE GALLO), 98049 VILLAFRANCA TIRRENA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Laboratorio Farmaceutico Erfo S.p.A. is an innovative SME and Benefit Corporation operating in the nutraceutical sector. The company specializes in contract manufacturing, offering comprehensive services for the formulation, production, and packaging of food supplements and natural medicines for third-party brands. Its modern, ISO 9001:2015 certified facility produces a variety of pharmaceutical forms, including capsules, tablets, sachets, vials, and bottles. Erfo provides a full-service 'all-in-one' solution that encompasses R&D, legal consulting, copywriting, and packaging design. The company prioritizes high-quality raw materials, sourcing extracts from global phytotherapeutic traditions, and supports clients with flexible production, including small batches.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Laboratorio Farmaceutico Erfo. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-09 11:14
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 377.2 KB
2025-08-02 09:19
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 375.9 KB
2025-07-25 20:05
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 374.5 KB
2025-07-18 20:04
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 377.1 KB
2025-07-12 09:39
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 375.4 KB
2025-07-04 18:21
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 373.3 KB
2025-07-02 20:45
Director's Dealing
Comunicazione internal dealing
Italian 87.4 KB
2025-06-28 14:02
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 373.9 KB
2025-06-21 09:57
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 373.7 KB
2025-06-21 09:36
Share Issue/Capital Change
Laboratorio Farmaceutico Erfo S.p.A. - Chiusura del terzo periodo di esercizio …
Italian 429.5 KB
2025-06-14 16:38
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 375.4 KB
2025-06-06 23:00
Transaction in Own Shares
Laboratorio Farmaceutico Erfo S.p.A. - Informativa settimanale acquisto azioni …
Italian 373.0 KB
2025-06-06 07:37
Share Issue/Capital Change
Laboratorio Farmaceutico Erfo S.p.A. - Apertura del terzo periodo di esercizio …
Italian 431.3 KB
2025-05-22 22:30
Earnings Release
Laboratorio Farmaceutico Erfo S.p.A. - Comunicazione dati gestionali IQ 2025
Italian 493.8 KB
2025-05-21 08:15
Environmental & Social Information
Erfo presenta Osteo-therapy ed entra nel mercato dell’impiantologia dentale
Italian 379.7 KB

Automate Your Workflow. Get a real-time feed of all Laboratorio Farmaceutico Erfo filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Laboratorio Farmaceutico Erfo via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mochida Pharmaceutical Co.,Ltd. Logo Japan 4534
Modalis Therapeutics Corporation Logo Japan 4883
MORISHITA JINTAN CO.,LTD. Logo Japan 4524
MUROMACHI CHEMICALS INC. Logo Japan 4885
Nanexa AB Logo
Develops long-acting injectables using its proprietary nanotechnology for its own pipeline and partners.
Sweden NANEXA
Nanoform Finland OYJ Logo
Pharma tech firm engineering nanoparticles to enhance drug performance and development.
Finland NANOFH
NANO MRNA Co.,Ltd. Logo Japan 4571
NanoRepro AG Logo
Develops and distributes rapid diagnostic self-tests for early disease detection.
Germany NN6
NATAC Logo
Develops sustainable, science-backed botanical extracts for global health and nutrition markets.
Spain NAT
Navamedic Logo
Develops and supplies pharmaceuticals, consumer health goods, and hospital products in the Nordics.
Norway NAVA